Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis

NCT01287182 is registered in ClinicalTrials.gov with Omicron Pharmaceuticals as lead sponsor.

NCT NCT01287182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01287182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis
Lead sponsor
Omicron Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2011
Completion date
December 31, 2011
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis